Skip to content

Clinical trials

Phase 1 Diabetes Mellitus, Type 1 trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus, Type 1 Phase: Phase 1 Country / region: United States Clear all

136 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20035
20042
20052
20063
20077
20087
20095
20109
20117
201211
20139
20144
20157
20168
20176
20183
20194
20207
20213
20227
20233
20244
20255
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed107
Recruiting12
Terminated7
Active, not recruiting3
Withdrawn3
Unknown status2
Not yet recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Yale University8
Eli Lilly and Company5
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)5
Sansum Diabetes Research Institute5
University of Maryland, Baltimore5
Stanford University4
AstraZeneca3
Baylor Research Institute3
National Institute of Allergy and Infectious Diseases (NIAID)3
Novo Nordisk A/S3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus, Type 1136
Diabetes Mellitus36
Diabetes Mellitus, Type 213
Insulin Resistance12
Hypoglycemia11
Hyperglycemia5
Autoimmune Diseases4
Diabetic Nephropathies3
Obesity3
Overweight3

Trials

Showing 1 to 25 of 136. Each trial links to its page on Pharma Observatory.

36 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.